Company / Cash per Share
Thermo Fisher Scientific Cash per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$25.39
FY2025
5-year range
$10.18 / $25.39
FY2021-FY2025
Trend
+149.5%
vs FY2024
Sector context
#13 of 146
Health Care
What the data says
Among 146 Health Care companies, Thermo Fisher Scientific is in the top 9% for cash per share. Cash per Share returned to growth in FY2025 after 2 years of decline, reaching $25.39.
Based on SEC 10-K filings.
25.39 in FY2025 with a 5-year CAGR of -0.0%. Top quartile in the Health Care sector.
Improved from $20.35 to $25.39 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +5.9%
- 5-Year CAGR
- -0.0%
- 10-Year CAGR
- -
Sector benchmark
Top 9% in Health CareTop 9% of 146This company $25.39 Sector average $27.73
▼
-8.4% below sector average
Key checks
Key Insights
- In FY2025, cash per share increased 149.5% year-over-year.
- Ranks #13 out of 146 companies in the Health Care sector.
- Peak cash per share was recorded in FY2020.
- Lowest cash per share in the period was in FY2016.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $25.39 | +149.5% |
| FY2024 | $10.18 | -50.0% |
| FY2023 | $20.35 | -4.8% |
| FY2022 | $21.36 | +92.3% |
| FY2021 | $11.11 | -56.3% |
| FY2020 | $25.43 | +321.9% |
| FY2019 | $6.03 | +13.8% |
| FY2018 | $5.30 | +59.5% |
| FY2017 | $3.32 | +70.0% |
| FY2016 | $1.95 | +58.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026